Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2005
04/27/2005CN1610667A 3-nitropyridine derivaives and the pharmaceutical compositions containing said derivatives
04/27/2005CN1610666A Benzamidine derivative
04/27/2005CN1610548A Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension
04/27/2005CN1610547A N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor
04/27/2005CN1610546A 病毒聚合酶抑制剂 Viral polymerase inhibitor
04/27/2005CN1609104A Dry distillation process of extracting nicotine from tobacco stem
04/27/2005CN1198839C Novel dipeptide amidines as thrombin inhibitors
04/27/2005CN1198823C Phenyl substituted 4-hydroxy tetrahydropyridone
04/27/2005CN1198820C N-substituted nitrogen heterocyclic compound
04/27/2005CN1198818C Compound with growth hormone releasing properties
04/27/2005CN1198817C N-(imidazolylalkyl) substituted cyclic amines as histamine-H3 agonists or antagonists
04/27/2005CN1198816C Farnesyl protein transferase inhibitors
04/27/2005CN1198807C 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical composition containing the same
04/27/2005CN1198806C Oxodiethylenediamine derivative and light stabilized composition
04/27/2005CN1198803C Heterocyclic compounds having effect of activating nicoting acetylchloine alpha 4 beta 2 receptor
04/27/2005CN1198613C Aminophenoxyacetic acid derivatives and pharmaceutical composition containing the same
04/27/2005CN1198605C Compound with 5-HT1A activity useful for treating disorders of outer retina
04/26/2005US6884890 Anticancer, antitumor agents, antiarthritic agents
04/26/2005US6884821 Alkyloxypropanoic acid derivative containing sulfonamide or amide group are useful as insulin resistance agent
04/26/2005US6884815 An amino compound containing imidazole and aromatic, or heteroaromatic rings is useful for treating inflammatory and immune system disorders
04/26/2005US6884810 Benzimidazole derivatives
04/26/2005US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases
04/26/2005US6884804 Inhibitors of Src and other protein kinases
04/26/2005US6884803 Phenylalkynes
04/26/2005US6884802 Phenanthridines substituted in position 6 by a mono, bi- or tricyclic heteroaryl radical; cyclic nucleotidephosphoesterase (PDE4) inhibitor and useful for treating respiratory system disorders
04/26/2005US6884801 Nitrogen compounds such as N-(4,5-dihydro-1H-imidazol-2-yl-methyl)-2-(methylsulfonyl)aniline, used for prophylaxis of incontinence
04/26/2005US6884437 Administration form comprising an acid-labile active compound
04/26/2005CA2280137C Sizing of paper
04/26/2005CA2239053C Diphenyl pyridyl ethane derivatives as pde iv inhibitors
04/26/2005CA2053253C New aryl-and heteroarylethenylene derivatives and process for their preparation
04/21/2005WO2005035528A2 Triazole derivatives as antibacterial agents
04/21/2005WO2005035527A1 Substituted pyrazinone compounds for the treatment of inflammation
04/21/2005WO2005035526A1 Bicyclic compounds and their therapeutic use
04/21/2005WO2005035525A2 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease
04/21/2005WO2005035524A1 Pyrrolidinyl urea derivatives as angiogensis inhibitors
04/21/2005WO2005035523A1 Fused lactam compounds
04/21/2005WO2005035522A1 1-‘2-(4-hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists
04/21/2005WO2005035521A1 Substituted quinolines as mcr modulators
04/21/2005WO2005035520A1 Substituted isoquinolinones
04/21/2005WO2005035510A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy
04/21/2005WO2005035508A2 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides
04/21/2005WO2005035507A2 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders
04/21/2005WO2005035506A1 Novel indazole derivative
04/21/2005WO2005035504A2 5-h -benzo [d] naphth [2, 1-b] azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders
04/21/2005WO2005035503A1 Novel isoquinoline derivative
04/21/2005WO2005035500A2 Therapeutic agents useful for treating pain
04/21/2005WO2005035499A1 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
04/21/2005WO2005035498A1 Use of nitrogenous bicyclic compound as feeding control agent
04/21/2005WO2005035496A1 Process for the preparation of n-amino substituted heterocyclic compounds
04/21/2005WO2005035495A2 Fibrinogen receptor antagonists and their use
04/21/2005WO2005035471A1 Ether derivative
04/21/2005WO2005034955A1 Substituted quinolines as protein tyrosine kinase enzyme inhibitors
04/21/2005WO2005034953A1 Angiogenesis inhibitor
04/21/2005WO2005034947A1 Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
04/21/2005WO2005034941A1 Indoles and azaindoles as antiviral agents
04/21/2005WO2005034870A2 Amide compounds and ion channel ligands and uses thereof
04/21/2005WO2005034867A2 Thioether-substituted benzamides as inhibitors of factor xa
04/21/2005WO2005023807A3 4 - heterobicyclyamino - substituted quinazolines and analogues therof as capsaicin - antagonists
04/21/2005WO2005022161B1 Chemiluminescent compounds
04/21/2005WO2005011697A3 Sulfonamide derivatives with activity on protein kinase a and b
04/21/2005WO2005005414A3 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
04/21/2005WO2005004803A3 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
04/21/2005WO2005004801A3 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives
04/21/2005WO2005004606A3 Pyridinylanilides
04/21/2005WO2004111029A8 Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
04/21/2005WO2004106322A3 Polymorphs of aripiprazole
04/21/2005WO2004089286A3 Novel compounds and compositions as protein kinase inhibitors
04/21/2005WO2004082616A3 Tetrahydropyranyl cyclopentyl heterocylic amide modulators of chemokine receptor activity
04/21/2005WO2004031174A8 Imidazol-1-ylmethyl pyridazine derivatives
04/21/2005US20050085639 Circulation disorders; antiproliferative agents; hypotensive agents; cardiovascular disorders; antiischemic agents; kidney disorders; atherosclerosis; restenosis; antiinflammatory agents; respiratory system disorders; angiogenesis inhibitors; anticancer agents; antiulcer agents
04/21/2005US20050085549 Hetrocyclic aryl sulphonamides
04/21/2005US20050085527 Catalysts for the polymerization of unsaturated compounds
04/21/2005US20050085520 amidation and/or dehalogenation to form substituted [4-carbamoyl-2-hydroxypentyl]-benzamides; potent enzyme inhibitors of Asp2 [B-secretase, BACE1 (b-site Alzheimer's amyloid precursor protein cleaving enzyme) or Memapsin]; Alzheimer's disease
04/21/2005US20050085514 Psychological disorders; schizophrenia; anxiolytic agents; antidepressants; bipolar diseases; circadian rhythm disorders; analgesics; Parkinson's disease; Huntington's disease
04/21/2005US20050085512 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor
04/21/2005US20050085511 Cyclic diamines and derivatives as factor Xa inhibitors
04/21/2005US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders
04/21/2005US20050085508 Gastrointestinal disorders; antiemetic agents; irritable bowel disorders; antipruritic agents
04/21/2005US20050085507 p-phenylethenyl hydroxamates; anticarcinogenic, antitumor, antiproliferative agents; regulating p21 promoter; improved stability
04/21/2005US20050085502 Phenyl-substituted imidazopyridines
04/21/2005US20050085501 Phenyl-substituted imidazopyridines
04/21/2005US20050085497 Anticholesterol agents; reducing blood serum lipids; anticancer agents; antiarthritic agents; antiinflammatory agents; antitumor agents; immunosuppressants; obesity; hypotensive agents
04/21/2005US20050085496 Microbiocidal n-phenyl-n-{4-(4-pyridyl)-2-pyrimidin-2-yl}-amine derivatives
04/21/2005US20050085488 nitrogen compounds used as preferential inhibitors of cyclic peptide, for prophylaxis of metabolic disorders
04/21/2005US20050085487 Heterocyclic compounds
04/21/2005US20050085482 Anticancer agents
04/21/2005US20050085476 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants
04/21/2005US20050085473 Novel triarylimidazoles
04/21/2005US20050085467 Androgen receptor antagonists
04/21/2005US20050085466 such as 1-[4-(2-oxo-4-trifluoromethyl-1,2-dihydroquinolin-6-ylmethyl)benzenesulfonyl]-piperidine-3-carboxylic acid ethyl ester; for treatment of acne, alopecia, and oily skin; kits
04/21/2005US20050085465 Quinazoline compounds
04/21/2005US20050085459 Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
04/21/2005US20050085458 Heterocyclic compounds possessing affinity at 5ht1-type receptors and use thereof in therapy
04/21/2005US20050085457 Therapeutic quinolone compounds with 5-ht-antagonistic properties
04/21/2005US20050084835 Karaoke system with built-in camera
04/21/2005US20050081313 And an oxidation base; couplers such as N-(3,5-diaminopyrid-2-yl)pyrrolidine; strong, uniform dyeing results between the end and the root, resistant to external agents, capable of giving varied shades
04/21/2005US20050081312 1-(2,4-dimethylphenyl)-4,5-diamino-1H-pyrazole dihydrochloride, ready-to-apply dyeing mixture for oxidative dyeing; brilliant color shades, improved color resistance to shampooing on hair varying greatly in quality, particularly on hair damaged by permanent waving or bleaching
04/21/2005CA2542031A1 Pyrimidine derivatives for treatment of hyperproliferative disorders
04/21/2005CA2541831A1 1-'2-(4-hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists
04/21/2005CA2541809A1 Thioether-substituted benzamides as inhibitors of factor xa
1 ... 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 ... 1080